Introduction
The q13 ± 15 segment of chromosome 12 is frequently ampli®ed in human sarcomas of various kinds (Roberts et al., 1989; Forus et al., 1991 Forus et al., , 1993 Forus et al., , 1994 Oliner et al., 1992; Smith et al., 1992; Khatib et al., 1993; Flùrenes et al., 1994) . In our sarcoma panel, the most frequently ampli®ed genes were MDM2, CDK4 and SAS, but none of these were included in all amplicons (Forus et al., 1993; Maelandsmo et al., 1995; Berner et al., 1996) . It seems likely that ampli®cation could be selected for by over-production of mdm2, a protein that binds to and inactivates the tumor suppressor p53 (Momand et al., 1992) . Cyclin-dependent kinase 4 (cdk4), on the other hand, under certain conditions phosphorylates the retinoblastoma tumor suppressor protein (pRB), releasing pRB-mediated G 1 arrest (Ewen et al., 1993) . Thus, by ampli®cation of this chromosomal segment, both these two major growth regulatory pathways may be inhibited. We have previously found discrete amplicons around MDM2 and CDK4, suggesting that there is separate selection for ampli®cation of the two genes, and making a common selective gene located in the intergenic region unlikely (Berner et al., 1996) .
The region around MDM2 is shown to harbor recurrent breakpoints in a variety of benign solid tumors (Schoenmakers et al., 1994; . Recently, the HMGIC gene was localized to this multiple aberration region' (MAR) and reported to be target for translocation in eight dierent benign solid tumor types Schoenmakers et al., 1995b) . HMGIC encodes a member of the family of high mobility group (HMG) proteins, characterized by AT-hooks; DNA binding domains that are able to bind to the minor groove of DNA (Reeves and Nissen, 1990) . These proteins may modulate DNA conformation and are thought to be architectural elements in the assembly of transcriptional complexes (Grosschedl et al., 1994; Wollfe, 1994) . The hmgic protein is abundant only in transformed cells, and a correlation between an elevated level of hmgic and a malignant phenotype has been demonstrated (Patel et al., 1994; Chiappetta et al., 1995) . Furthermore, it has been shown that expression of antisense HMGIC is able to prevent retrovirally induced tumor progression in rat thyroid cells .
In this study we have determined the ampli®cation status of this gene in 122 human sarcomas. We have further analysed the involvement of 11 loci mapped within MAR in 21 human sarcomas with 12q13 ± 15 ampli®cation, and rearrangement of HMGIC was studied in a subset of sarcomas by Northern and 3' RACE analysis.
Results

Ampli®cation of MAR loci
We have previously detected ampli®cation in the q13 ± 15 region of chromosome 12 in a large panel of human sarcomas by molecular analysis and comparative genomic hybridization (CGH) (Forus et al., 1993 (Forus et al., , 1995a Maelandsmo et al., 1995; Berner et al., 1996) . Here we used Southern blot hybridization to determine the ampli®cation pattern of HMGIC in essentially the same panel, consisting of 122 human sarcomas. Using a probe from the 5' part of HMGIC, including the coding region (probe B), we detected ampli®cation of HMGIC in 13 of the sarcomas (10%), all samples with previously detected ampli®cation in the 12q13 ± 15 region . The relative copy numbers of sequences  surrounding HMGIC; RM14, RM4, RM7, RM46,  EST01096, RM69, RM51, RM103, RM108, RM98 and RM36, were analysed in these and eight other samples in which ampli®cation in the 12q13 ± 15 region was previously detected.
Quantitation of signal intensities was done by twodimensional laser densitometry, and representative Southern blots are shown in Figure 1 . Based on these values, relative to signals from a normal control probe, ampli®cation was classi®ed as low-level (three-to ®vefold increase), moderate (®ve-to tenfold increase) or high (more than tenfold increase). The results are summarized in Figure 2 . None of the loci were consistently ampli®ed, and in most cases a complex pattern of ampli®cation with many discontinuities was observed. RM46, a marker very close to MDM2 (Kools et al., manuscript in preparation) , was ampli®ed most frequently, in 17 cases, and generally at high levels. This parallels the ampli®cation status of MDM2 completely (Berner et al., 1996) . The RM7 locus, a little further away from MDM2, was included in 14 amplicons and showed high level ampli®cation in nine cases. HMGIC was ampli®ed in 13 cases and in six cases at high levels. Other sequences, from the region between HMGIC and MDM2 (RM46) and proximal to HMGIC, were ampli®ed in fewer samples (four to nine cases) and mostly at low to moderate copy number. Taken together, these results indicate Leukocyte DNA was included as a control for normal copy number, and a probe for APOB was used to calibrate for unequal sample loading. An A below the panel indicates an ampli®cation of the corresponding sequence (a signal at least three times more intense than the signal from normal DNA). Please note the rearrangement within HMGIC in LS11, LS22 and HP1x, and the dierences in ampli®cation status between LS28x, LS41 and OSA when using probe B and probe C, from the 5' and 3' part of HMGIC, respectively (b) discrete amplicons around the two genes MDM2 and HMGIC.
In the two malignant ®brous histiocytoma (MFH) samples (MFH3x and MFH25) neither MDM2, CDK4 nor HMGIC were ampli®ed, although ampli®cation of sequences in 12q14 was detected by CGH (Forus et al., 1995a) . We have previously shown that D12S8 was ampli®ed at low levels in MFH25 (Berner et al., 1996) , and here we show that RM4, located close to D12S8, detected a similar level of ampli®cation in this sample (Figure 2 ), whereas EST01096 detected ampli®cation in MFH3x. This could indicate that ampli®cation of genes other than MDM2, CDK4 and HMGIC may be important in MFH.
Rearrangement and preferential ampli®cation of the 5' part of HMGIC In addition to the described analysis with probe B, samples with HMGIC ampli®cations were further analysed with probe A, a probe from the 5' untranslated region, and probe C, from the 3' untranslated region of the gene. The results with probe A did not dier from those using probe B, whereas probe C did not detect ampli®cation in OSA, LS28/LS28x or LS41 (Figure 1) . Furthermore, probe C hybridized to aberrant restriction fragments in three other samples with ampli®cation; LS11, LS22 and HP1x. In LS11, probe C detected one unampli®ed normal restriction fragment and one larger fragment with more than tenfold amplification. Probe B also detected a rearranged or polymorphic restriction fragment in LS11, but not in LS22 or HP1x.
HMGIC expression analysis
Expression of HMGIC was analysed by Northern blotting in 28 sarcoma samples, including 23 liposarcomas ( Figure 3 and not shown). HMGIC Figure 2 Summary of the Southern blot analysis of 12q13 ± 15 amplicons in 21 human sarcomas. At the top is a schematic map (Schoenmakers et al., 1995a,b) of the loci with the centromere to the right. The tumor types and numbers are given to the left (FS, ®brosarcoma, HP, hemangiopericytoma, LS, liposarcoma, MFH, malignant ®brous histiocytoma, MS, malignant Schwannoma/ malignant peripheral nerve sheath tumor, OS, osteosarcoma, NCS, non classi®ed sarcoma). Probe B was used as a probe for the 5' part of HMGIC and probe C for the 3' part. The densitometrically determined levels of ampli®cation are divided into four categories as indicated. The numbers of samples with ampli®cation (more than threefold increase in copy number) are listed below for each locus. The D12S8 and CDK4 data have been published previously, and the results for RM46 are identical to those previously determined for MDM2 (Berner et al., 1996) probe B detected transcripts in 12 cases, including ®ve samples without ampli®cation of HMGIC (Table 1) . Five of the 12 cases showed mRNA sizes dierent from the wild-type transcript of about 4.3 kb. We observed shorter transcripts in the samples OSA (2 kb) and LS41 (1.2 kb) and a longer transcript in LS28/LS28x (6.1 kb), all of which were samples with dierent ampli®cation patterns of the 5' and 3' part of the gene. The expression levels in these three samples were higher than in the other samples analysed. Of the three samples with aberrant restriction fragments, but with ampli®cation also including the 3' part of HMGIC, LS22 showed a smaller transcript (1.7 kb, not shown) whereas apparently normal sized mRNA was observed in HP1x and LS11. Furthermore, one liposarcomas with no ampli®cation of HMGIC, LS13, expressed high levels of HMGIC of aberrant size. The samples were further analysed with probe C. As shown in Figure 3 , the abnormal HMGIC transcripts did not hybridize to this probe, demonstrating that the predominant mRNA species in those samples (LS13, LS28/LS28x, LS41 and OSA) have lost sequences from the 3' part.
3' RACE analysis
We further analysed the 1.2 kb transcript in LS41 by 3' RACE experiments. A PCR product of about 400 bp was obtained, puri®ed, cloned and sequenced. Figure 4 shows the nucleotide sequence of the RACE fragment, demonstrating sequences of unknown origin fused to exon 3 of HMGIC. Instead of exon 4 and 5 we found 
Discussion
The HMGIC gene, encoding a nuclear protein with DNA-binding properties, has recently been shown to be the target of translocations in various benign solid tumors Schoenmakers et al., 1995b) . The gene is located to 12q15, in the 1.7 megabase`multiple aberration region' (MAR) . The hmgic protein can bind to the minor groove of AT-rich DNA stretches (Reeves and Nissen, 1990) , and may modulate DNA bending. Thus, hmgic is believed to be an architectural element in the assembly of transcriptional complexes (Grosschedl et al., 1994; Wollfe, 1994) . HMGIC was ampli®ed in 13 out of 122 samples in our sarcoma panel, compared to 17 for MDM2 and 16 for CDK4 (Table 1 and Berner et al., 1996) . However, except for sequences close to MDM2, reduced copy numbers of sequences on either side of HMGIC were detected, and in many samples high levels of ampli®cation (more than tenfold) of HMGIC was observed. Although HMGIC was only ampli®ed together with MDM2, this suggests preferential inclusion of HMGIC, rather than passive coamplification with MDM2, probably because there is selection also for overexpression of HMGIC. The patterns of ampli®cations were complex, with many discontinueties, probably re¯ecting random ampli®cation breakpoints due to prolonged selection for increased dosage of the critical genes.
Interestingly, in a number of samples (LS28/LS28x, LS41 and OSA) we found dierent patterns of ampli®cation of the 5' and the 3' part of the HMGIC gene, suggesting that either a rearranged HMGIC is ampli®ed or that there are recurrent ampli®cation breakpoints within HMGIC (Figure 1) . Northern analysis con®rmed these data, showing strongly expressed HMGIC transcripts of aberrant sizes (Figure 3) . In three other samples, LS11, LS22 and HP1x, the 3' part of the gene was rearranged and both the 5' and the 3' parts were ampli®ed, but aberrant HMGIC mRNA was observed only in one of them (LS22). Interestingly, highly expressed HMGIC mRNA of aberrant size was also observed in a sample without ampli®cation of HMGIC, LS13. In all cases sequences from the 3' part were absent from the aberrant transcripts (Figure 3) .
Several studies of benign tumors of mesenchymal origin have detected ectopic transcripts resulting from the fusion of HMGIC and various translocations partners Kazmierczak et al., 1995 Kazmierczak et al., , 1996 Schoenmakers et al., 1995b) . These studies indicate that truncation of HMGIC, in most cases through loss of exon 4 and 5, rather than its fusion to speci®c ectopic coding sequences, is important for its oncogenicity. Most likely the resulting loss of the Cterminal acidic domain of hmgic results in some kind of deregulation. The nature of the rearrangement leading to aberrant HMGIC transcripts in sarcoma was investigated by 3' RACE analysis of one of the samples, showing replacement of exon 4 and 5 by ectopic sequences (Figure 4) . It is at present unknown whether this novel sequence is part of a gene and from which chromosomal region it originates. The resulting transcript codes for a truncated hmgic, in which the 26 C-terminal amino acids, including the acidic domain, are replaced by ten novel amino acids. A similar rearrangement of HMGIC has previously been reported for the osteosarcoma cell line OSA, in which the HMGIC gene was fused to ectopic sequences from the LUM gene in 12q22, encoding only three extra amino acids before the stop codon (Kools et al., 1996) .
As the biological function of HMGIC is poorly characterized, it is hard to speculate what the eect of the C-terminal truncation might be. However, as mice with mutant hmgic are almost devoid of adipose tissue and their ®broblasts have reduced growth rate in vitro, it seems likely that hmgic is important for mesenchymal proliferation and/or dierentiation . It is also possible that the various truncations aect the stability of the HMGIC mRNA or protein.
It is striking that HMGIC, which is involved in the speci®c translocation of lipomas, was ampli®ed in seven of the eight well dierentiated liposarcomas (WDLS) with ampli®ed 12q13 ± 15 sequences. WDLS are characterized by supernumerary abnormal chromosomes (rings or giant rod markers) containing sequences from the q13 ± 15 segment of chromosome 12 (Dal Cin et al., 1993) . We have previously shown that MDM2, but not CDK4, is consistently included in amplicons in WDLS (Pedeutour et al., 1994) . Sequences from several chromosomes contribute to these markers, making the generation of`secondary translocations' or of novel fusion genes within the markers likely. The suppression of p53 by MDM2 overexpression might be a prerequisite for the ampli®cation process generating the WDLS marker chromosome, thus explaining the need for coamplification of MDM2. One might speculate as to whether the Figure 4 Sequence from the part of the HMGIC fusion transcript in LS41 analysed by 3' RACE experiments showing ectopic sequences fused to HMGIC. The italic sequence is from the HMGIC gene, exon 3, and the ectopic sequence, starting from nucleotide 1, has been deposited in Genbank with the accession number U73513. The putative polyadenylation signal is underlined truncated HMGIC, as found in the benign tumors, might contribute to malignant transformation when overexpressed as reported here.
Materials and methods
Specimens
Sarcoma tissue of various histologic subtypes was obtained from 93 patients and from 32 xenografts grown in nude mice, including ®ve cases where both xenograft and patient sample from the same tumor were available. The material consisted of two carcinosarcomas, one chondrosarcoma, three ®brosarcomas, one hemangiopericytoma, 13 leiomyosarcomas, 31 liposarcomas, 24 malignant ®brous histiocytomas (MFH), seven malignant peripheral nerve sheath tumors (MPNST)/malignant Schwannomas, 22 osteosarcomas, three rhabdomyosarcomas, four synovial sarcomas and nine non-classi®ed sarcomas. One osteosarcoma (OSA) and one rhabdomyosarcoma (RMS13) cell line were also analysed (Roberts et al., 1989) . All tumors were classi®ed according to the WHO International Histological Classification of Tumours (Schajowich, 1993; Weiss, 1994) .
Southern blot analysis
DNA extraction from tumor samples, preparation of ®lter blots and hybridization were as described previously (Forus et al., 1993; Maelandsmo et al., 1995) . A signal at least three times more intense than signals from samples with normal copy number (peripheral blood leukocytes) was scored as an ampli®cation. Quantitation of signal intensity was done by two-dimensional densitometry on a Molecular Dynamics laser densitometer. The net signals from speci®c bands were corrected for unequal sample loading by calibration relative to the signal obtained from an APOB control probe. Average signals from at least two (and in most cases three) dierent blots were used to measure the ampli®cation levels in the tumors.
Northern blot analysis
RNA puri®cation, electrophoresis, transfer to ®lters and hybridization were as previously described (Forus et al., 1993) .
Rapid ampli®cation of cDNA ends (3' RACE)
Ampli®cation of the 3' cDNA ends was performed as described by Schoenmakers et al., 1995b , using the Gibco/ BRL protocol. For the cDNA synthesis we used the adapter primer (AP) 5'-GGCCACGCGTCGACTAG-TAC(T) 17 -3' from BRL. For ®rst and secondary rounds of PCR we used the universal ampli®cation primer (UAP) 5'-CUACUACUACUAGGCCACGCGTCGACTAGTAC-3' as reverse primer. In the ®rst round of PCR we used the speci®c forward primer (HMGIC exon 1) (5'-CTTCAGCC-CAGGGACAAC-3'), and in the second round of PCR the nested primer (HMGIC exon 1) (5'-CAUCAUCAU-CAUCGCCTCAGAAGAGAGGAC). PCR thermal cycling: 948C, 5 min; (948C, 1 min; 558C, 45 s; 728C, 3 min) 630, 728C, 10 min. Cloning of gel-extracted fragments was performed using the CloneAmp system (BRL). Sequenase version 2.0 DNA polymerase (USB) was used for the sequencing reactions.
Probes
The PCR products RM14, RM4, RM7, RM46, EST01096, RM69, RM51, RM103, RM108, RM98 and RM36 are from the MAR (multiple aberration region in 12q15) and from sequences distal to MAR, described by Schoenmakers (Schoenmakers et al., 1995a) . As probes for HMGIC we used probe A, an 83 bp PCR fragment of 5' non-translated sequences, probe B, the 5' part of the gene including the complete protein coding region, and probe C (pCH76), from the 3' untranslated end of the gene (Kools et al., 1996) . To calibrate for unequal loading of DNA, we used a probe for APOB (clone pB27) kindly provided by DJ Breslow (Huang et al., 1985) .
